tiprankstipranks
NewsSmart PortfolioMarkets
Research Tools
Research Tools
Top Stocks
Top Smart Score Stocks
New
Analysts' Top StocksInsiders' Hot Stocks
Popular
Trending Stocks
Daily Feeds
Daily Stock RatingsDaily Insider Transactions
Screeners
Stock Screener
New
Stock Comparison
New
Smart Portfolio
Smart Portfolio
My Portfolio
OverviewMy HoldingsMy Portfolio AnalysisCrowd Insights
My Community
My PerformanceMy Public Profile
New
Top Experts
Top Experts
Find & Follow Experts
My ExpertsExpert CenterTop Firms
Top Lists
Top 25 Wall Street AnalystsTop 25 Financial BloggersTop 25 Corporate InsidersTop 25 Hedge Fund ManagersTop Individual Investors
New
News
News
Categories
HomeMarket NewsTipRanks LabsIdeas & InsightsStock Analysis
Trending Topics
Coronavirus StocksDividend StocksPenny StocksFAANG Stocks
Calendars
Calendars
Calendars & Events
Earnings CalendarsDividend CalendarsStock Market HolidaysIPO Calendar
Plans & Pricing
NewsSmart PortfolioMarketsNotifications
All News

GLPG

Topic
Galapagos: Upside Optionality Remains Despite Clinical Trial Failure
Galapagos (GLPG) is far from a household name in the US, yet it remains a productive company that...
Alexander Poulos
GLPG
Vertex or Galapagos: Which Biotech Stock Does The Street Favor?
The COVID-19 pandemic had a mixed impact on pharma companies so far. During nationwide lockdowns, some companies benefited...
Sirisha Bhogaraju
GLPGVRTX
Galapagos Pops 9% On Positive Result Of Novesa Trial
Shares of Galapagos (GLPG) rose 8.8% on Friday after the company reported positive topline results in the Phase...
Amit Singh
GLPG
Gilead and Galapagos Score Positive Topline Results For Ulcerative Colitis Trial
Gilead Sciences (GILD) and Galapagos NV (GLPG) have announced positive topline results from a Phase 2b/3 trial evaluating...
Harriet Lefton
GILDGLPG